Free practice quiz
BCPP Prep Course (BCPP): free quiz
10 questions from the program. See your score right away, then unlock the explanation of every answer.
- Question 1 of 10
During medication reconciliation for a patient taking sertraline 100 mg by mouth each morning and trazodone 50 mg by mouth at bedtime, the psychiatric pharmacist reviews the initial interview note: “still hears voices, stopped meds before because they made me pace, drinks 4 beers nightly, mother had bipolar disorder.” Which additional psychiatric history question is most important to clarify first to distinguish a prior adverse effect from persistent target symptoms and guide safer psychotropic recommendations?
Why A is correct
Pacing after a psychotropic may reflect akathisia rather than worsening psychiatric illness. Clarifying the exact drug, timing after initiation or titration, and dechallenge response helps separate an adverse effect from target symptoms and prevents re-exposure to a poorly tolerated agent. This is a high-yield psychiatric history element because past response, tolerability, and adherence directly inform medication optimization.
NOTICE: Prior “pacing” linked to medication use. SAY: “Which medicine caused it, when did it begin, and did it improve when the dose changed or it was stopped?” MONITOR: Restlessness/EPS symptoms with each titration and follow-up. HOLD/CLARIFY/ESCALATE: Clarify before recommending re-trial of the same or similar dopamine-blocking drug; escalate urgently if severe agitation or safety risk emerges.
Why B is incorrect
This is tempting because substance use and smoking history matter in psychiatric care. However, prior nicotine-cessation treatment does not address the immediate need to distinguish an adverse effect from persistent symptoms. The eliminating fact is that the stem specifically asks about interpreting past pacing during psychotropic treatment.
NOTICE: Tobacco history can affect metabolism and counseling. SAY: Ask later during substance use review. MONITOR: Smoking status at routine visits. HOLD/CLARIFY/ESCALATE: Clarify promptly only if a CYP1A2-related regimen change is planned.
Why C is incorrect
This is tempting because adherence barriers and administration preferences are clinically relevant. The eliminating fact is that dosing-time preference does not determine whether prior pacing was akathisia, anxiety, or another medication-related adverse effect. It is secondary to clarifying past tolerability and drug-response chronology.
NOTICE: Convenience may improve adherence. SAY: Discuss schedule preferences after safety clarification. MONITOR: Refill gaps and self-reported adherence. HOLD/CLARIFY/ESCALATE: Escalate only if adherence problems are causing relapse or withdrawal risk.
Why D is incorrect
This is tempting because family psychiatric history can inform treatment selection. The eliminating fact is that family antidepressant experience without weight gain is less urgent than determining whether the patient previously experienced a medication-induced movement adverse effect. Family history informs later planning but does not answer the key safety question in the stem.
NOTICE: Family history may help with longitudinal regimen planning. SAY: Obtain first-degree family psychiatric and medication history after immediate tolerability issues are clarified. MONITOR: Update history when considering future class selection. HOLD/CLARIFY/ESCALATE: Clarify sooner if family history suggests a major risk that changes medication choice.
- Question 2 of 10
A patient says she plans to drive herself home despite feeling extremely sedated and unsteady after taking a newly started psychotropic medication. Which MSE domain is most directly relevant to the pharmacist’s medication safety concern?
A. This is correct. Judgment is a listed MSE domain and is directly relevant to safe decision-making. The patient’s plan to drive while sedated and unsteady affects medication safety, a key emphasis of the source node.
B. This is incorrect. Affect refers to observed emotional expression. The concern is unsafe decision-making rather than emotional expression.
C. This is incorrect. Mood refers to the patient’s reported emotional state. The stem does not center on how the patient feels emotionally.
D. This is incorrect. Thought content refers to beliefs or ideas. Although the patient expresses a plan, the medication safety issue is best categorized as impaired or questionable judgment.
- Question 3 of 10
A pharmacist is creating a monitoring plan for a patient with depressive symptoms, anxiety symptoms, and concern for medication-related abnormal movements. What is the best approach to scale selection?
A. This is correct because the source pack emphasizes knowing scale purpose, interpretation, and limitations and lists different high-yield scales for different monitoring needs.
B. This is incorrect because PHQ-9 is not a universal replacement for anxiety, suicide risk, movement monitoring, or broad psychiatric symptom assessment.
C. This is incorrect because AIMS does not replace symptom scales such as PHQ-9 or GAD-7 when the assessment purpose differs.
D. This is incorrect because the source pack supports scale use for baseline and follow-up monitoring when interpreted appropriately.
- Question 4 of 10
A patient with a recent suicide attempt presents for a first outpatient medication visit after discharge. The patient appears visibly agitated and states they have not disposed of old medication bottles. What is the most important medication-related safety issue?
A. This is incorrect because dosing convenience may affect adherence, but it is not the immediate safety issue in a patient with recent attempt and medication access.
B. This is correct because medication access and overdose risk are specifically emphasized as red flags in the source pack.
C. This is incorrect because pharmacy continuity may support medication history but does not directly address overdose risk.
D. This is incorrect because package insert review is not the central safety priority when suicide risk red flags are present.
- Question 5 of 10
Which rationale best explains why psychiatric pharmacists should be involved in mental health crisis presentations?
A. Correct. This statement integrates the node’s emphasis on medication-related contributors and urgent hazards with blueprint topics such as adverse effects, adherence, substances, medication history, and comprehensive medication management.
B. Incorrect. The node says to confirm local emergency protocols when needed; it does not support replacing protocols with pharmacist-only algorithms.
C. Incorrect. The source pack directly connects crisis assessment to medication-related contributors and drug-related problems.
D. Incorrect. Counseling and education are part of psychiatric pharmacy practice, but the selected topic focuses on acute crisis presentations and team-based response.
- Question 6 of 10
A patient says, "I know taking my medication would help, but I always forget because I work two jobs." Which pharmacist response best supports behavior change using motivational interviewing principles?
A. This is incorrect because it is judgmental and does not explore barriers. The source pack identifies motivational interviewing as useful for adherence.
B. This is correct because it is an open question that elicits patient-generated change strategies. Motivational interviewing supports behavior change and addresses adherence barriers.
C. This is incorrect because it gives a solution before eliciting the patient's perspective. Motivational interviewing prioritizes open questions and collaborative counseling.
D. This is incorrect because it makes an unsupported therapy conclusion. The pharmacist role described in the source pack is counseling-focused.
- Question 7 of 10
Which scenario best illustrates the need to link medication formulation choice to real-world access barriers?
A. This is correct because housing and transportation barriers are listed in the source pack, and formulation choice should be linked to real-world access barriers. This scenario directly affects adherence feasibility.
B. This is incorrect because chemical structure questions do not describe access or formulation feasibility. The node focuses on social determinants and access.
C. This is incorrect because there is no access barrier to address. The prompt asks for a scenario requiring linkage between formulation and barriers.
D. This is incorrect because a scheduling preference without feasibility limitations is less directly related to social determinants. The stronger example involves access barriers that affect medication use.
- Question 8 of 10
A patient reports missing doses after a medication change from once daily to three times daily. The patient denies side effects and states they want to continue treatment. What is the most likely adherence barrier?
A. This is correct because the increased dosing frequency makes the regimen more complex, and the patient wants treatment but misses doses, suggesting unintentional nonadherence.
B. This is incorrect because the patient states a desire to continue treatment and does not describe negative medication beliefs.
C. This is incorrect because the patient denies side effects.
D. This is incorrect because the patient is not refusing medication; the barrier is practical complexity after the dosing change.
- Question 9 of 10
A pharmacist is evaluating laboratory results for a patient receiving ongoing psychotropic therapy. One value is slightly outside the reference range, but previous results show a gradual upward pattern over several visits. What is the best interpretation strategy?
A. This is incorrect. The source pack explicitly emphasizes interpreting trends rather than isolated values alone.
B. This is incorrect because abnormal flags do not replace clinical interpretation of trends, baseline needs, and psychotropic safety monitoring.
C. This is correct. The selected node highlights that laboratory monitoring should consider trends over time, not just one result in isolation.
D. This is incorrect. The source pack does not limit trend interpretation to hospitalized patients; trend-based interpretation is a general laboratory monitoring principle relevant to psychiatric pharmacy practice.
- Question 10 of 10
A patient with baseline generalized anxiety disorder reports worsened restlessness and insomnia. The pharmacist notices an anticholinergic medication was added recently for another condition. What is the best next step?
A. This is correct because anticholinergics are listed as possible contributors, and the source pack emphasizes review of timelines and medication changes.
B. This is incorrect because a known psychiatric diagnosis does not rule out medication-induced worsening.
C. This is incorrect because the selected node specifically requires assessment of medications that may cause or worsen psychiatric symptoms, including nonpsychiatric agents.
D. This is incorrect because adherence problems are only one possible issue; drug-related psychiatric worsening can occur even when psychiatric medications are continued.
See why each answer is right or wrong
Enter your email to unlock the explanation of every question, free.


